menu search

An Old Dog with a New Trick… Ellodi’s APT-1011 Promises EoE Patients a Convenient and Potent Treatment Alternative

An Old Dog with a New Trick… Ellodi’s APT-1011 Promises EoE Patients a Convenient and Potent Treatment Alternative
Spherix Global Insights finds doctors have yet to define where APT-1011 will sit in the treatment path relative to EoE treatment gold standard, Dupixent. Exton, Pennsylvania, Aug. 15, 2023 (GLOBE NEWSWIRE) — Since launching in May 2022, Sanofi/Regeneron’s Dupixent has been well received by gastroenterologists and allergists as an advancement for treating eosinophilic esophagitis (EoE). […] The post An Old Dog with a New Trick… Ellodi’s APT-1011 Promises EoE Patients a Convenient and Potent Treat... Read More
Posted: Aug 15 2023, 19:40
Author Name: forextv
Views: 092060

Search within

Pages Search Results: